Vaccines for maternal immunization against Group B Streptococcus disease: WHO perspectives on case ascertainment and case definitions
Open Access
Abstract
No abstract availableKeywords
Funding Information
- The Wellcome Trust (205184)
- Bill & Melinda Gates Foundation (OPP1134011)
This publication has 57 references indexed in Scilit:
- Considerations for a phase-III trial to evaluate a group B Streptococcus polysaccharide-protein conjugate vaccine in pregnant women for the prevention of early- and late-onset invasive disease in young-infantsVaccine, 2013
- Care Seeking for Neonatal Illness in Low- and Middle-Income Countries: A Systematic ReviewPLOS Medicine, 2012
- Vaginal–Perianal Compared With Vaginal–Rectal Cultures for Detecting Group B Streptococci During PregnancyObstetrics & Gynecology, 2011
- A multiplex PCR assay for the direct identification of the capsular type (Ia to IX) of Streptococcus agalactiaeJournal of Microbiological Methods, 2010
- Clinical signs that predict severe illness in children under age 2 months: a multicentre studyThe Lancet, 2008
- Serotype IX, a Proposed New Streptococcus agalactiae SerotypeJournal of Clinical Microbiology, 2007
- Specimen Storage in Transport Medium and Detection of Group B Streptococci by CultureJournal of Clinical Microbiology, 2005
- Why are 4 million newborn babies dying every year?The Lancet, 2004
- Multicenter evaluation of the reproducibility of the proposed antifungal susceptibility testing method for fermentative yeasts of the Antifungal Susceptibility Testing Subcommittee of the European Committee on Antimicrobial Susceptibility Testing (AFST-EUCAST)Clinical Microbiology and Infection, 2003
- Perianal versus anorectal specimens: is there a difference in Group B Streptococcal detection?2002